| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |